Literature DB >> 3553756

Marijuana testing--how good is it?

T P Moyer, M A Palmen, P Johnson, J R Charlson, P J Ellefson.   

Abstract

Testing for the use of marijuana necessitates one or more levels of assessment, depending on the clinical application of the test results. The EMIT-dau screening test with a sensitivity limit of 20 ng/ml is highly satisfactory for screening for the absence of marijuana in the urine. This test has a virtual 100% true-negative rate as long as an unadulterated urine specimen is analyzed. Positive results by the EMIT-dau procedure are presumptive because the test seems to produce false-positive results when applied to a random population of suspected drug users. In a population in a specific clinical environment such as in drug-treatment programs in which 20 of every 100 specimens will yield positive THC-COOH results by EMIT-dau screening, 3 (15%) of the 20 positive results will likely be false-positive. Our experience with the EMIT-dau suggests that of 100 test results, 3 will be false-positive, an overall 3% false-positive rate. If a positive test result will put the patient in considerable jeopardy and the screening result is the only evidence of drug use, confirmatory testing is imperative. Of the confirmatory tests, GC/MS seems to have the specificity necessary to provide a high level of confidence in the results. A combination of the EMIT procedure with a sensitivity level of 20 ng/ml and GC/MS confirmation yields virtually 100% accuracy in detection of marijuana abuse.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3553756     DOI: 10.1016/s0025-6196(12)65447-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  2 in total

1.  Marijuana testing.

Authors:  I N Stein
Journal:  West J Med       Date:  1988-01

2.  Minocycline attenuates oxycodone-induced positive subjective responses in non-dependent, recreational opioid users.

Authors:  S Mogali; P Askalsky; G Madera; J D Jones; S D Comer
Journal:  Pharmacol Biochem Behav       Date:  2021-07-21       Impact factor: 3.697

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.